Our reader got spooked by a stock market crash and now has a lot of cash to put to work. Val Cipriani takes a look ...

In today’s equity markets, investors face a paradox: share price swings are more dramatic than ever yet often have little to do with a company’s underlying health or earnings. So how can investors ...

Strategy has shifted to AI factories, agentic systems, and platform-infused engineering. And executives speak of productivity ...

An updated edition of the September 24, 2025, article. The U.S. robotics landscape has experienced transformative growth through late 2025, with the third quarter marking unprecedented technological ...

Kyverna Therapeutics (KYTX) is rated a strong buy with promising KYV-101 Phase 2 data and near-term catalysts. Read here for ...